title: Five-year follow-up of the ABSORB bioresorbable everolimus-eluting vascular scaffold system: multimodality imaging assessment.
authors.affiliation: Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands.
authors.forename: Héctor M
authors.initials: HM
authors.lastname: García-García
authors.forename: Carl
authors.initials: C
authors.lastname: Schultz
authors.forename: Eric
authors.initials: E
authors.lastname: Duckers
authors.forename: Evelyn
authors.initials: E
authors.lastname: Regar
authors.forename: Jurgen
authors.initials: J
authors.lastname: Ligthart
authors.forename: Patrick W
authors.initials: PW
authors.lastname: Serruys
authors.forename: Robert J
authors.initials: RJ
authors.lastname: van Geuns
mesh_terms: D020341:Absorbable Implants; D015906:Angioplasty, Balloon, Coronary; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000628:therapy*; D054855:Drug-Eluting Stents; D000068338:Everolimus; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives*; D054457:Tissue Scaffolds; D018084:Ultrasonography, Interventional
chemical_list: D000068338:Everolimus; D020123:Sirolimus